Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.
1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556
Next »

Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.

March 18, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.

Week Of March 8, 2010: Company And People Notes: Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

March 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

Week Of March 1, 2010: Company And People Notes: Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

March 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

A Bio View of Outsourcing

March 3, 2010
By:Eric Langer
PTSM: Pharmaceutical Technology Sourcing and Management

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.

Strategic Sourcing Focuses on Risk Mitigation

March 2, 2010
By:Patricia Van Arnum
Pharmaceutical Technology

Pharmaceutical companies and their suppliers share approaches in risk mitigation in sourcing and ways to optimize the outsourced relationship.

Uptick or Sustainable Growth?

March 2, 2010
By:Patricia Van Arnum
Pharmaceutical Technology

Contract manufacturers report improving business conditions, but will they continue?

Consumers Need Access to Lower-Cost Biogenerics

March 2, 2010
By:Kathleen Jaeger
Pharmaceutical Technology

To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.

Skinny or Dead

March 2, 2010
By:Michelle Hoffman
Pharmaceutical Technology

If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.

Baxter International's Shaun Newlon on Manufacturing Trends

March 2, 2010
Pharmaceutical Technology

The vice-president addresses shifts in process and more.

1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556
Next »

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
In light of the fact that most of the world is now out of the recession, how is your company faring compared with this time last year?
Better
Worse
About the same
Better
57%
Worse
26%
About the same
17%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Featured Jobs

More Jobs

Click here